Canada Life
TBIO

Canada Life’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Canada Life’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,091
Closed -$58K – 2558
2021
Q2 		$58K Sell
2,091
-1,271
-38% -$25K ﹤0.01% 2226
2021
Q1 		$55K Buy
3,362
+1,217
+57% +$27.7K ﹤0.01% 2265
2020
Q4 		$39K Hold
2,145
– – ﹤0.01% 2374
2020
Q3 		$29K Hold
2,145
– – ﹤0.01% 2342
2020
Q2 		$38K Hold
2,145
– – ﹤0.01% 2319
2020
Q1 		$21K Hold
2,145
– – ﹤0.01% 2367
2019
Q4 		$17K Buy
+2,145
New +$19.8K ﹤0.01% 2540

Canada Life's TBIO Position: Q3 2021 in Review

Canada Life sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 2,091 shares — an estimated $58K sold.

Canada Life first reported a position in TBIO in Q4 2019 and held it in 7 quarters. The position peaked at $58K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Canada Life reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Canada Life sold 2,091 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $58K.
  • Canada Life first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Canada Life's Translate Bio, Inc. Common Stock position peaked at $58K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Canada Life's 13F filing for Q3 2021, filed 15 Nov 2021.